Based on the data revealing a key role of SGLT1 transporter in increased intestinal glucose absorption and resulting hyperglycemia in diabetes, a new approach to reduce postprandial hyperglycemia using SGLT1 inhibitors seems promising for the treatment of diabetic patients [8,109]. The gene discussed is SLC5A1; the disease is Hyperglycemia.